Filter
172
Text search:
unhealthy
products
Featured
Recommendations
11
New Publications
46
Language
Document type
No document type
70
Studies & Reports
58
Guidelines
24
Strategic & Response Plan
12
Training Material
3
Manuals
2
Fact sheets
2
Resource Platforms
1
Countries / Regions
Global
20
India
14
Western and Central Europe
7
South–East Asia Region
6
Ghana
5
Zambia
5
Philippines
4
Kenya
4
Malawi
4
Nigeria
3
Myanmar / Burma
3
Eastern Europe and Central Asia
3
Africa
3
Sierra Leone
2
Zimbabwe
2
Nepal
2
Botswana
2
Eastern Europe
2
Moldova
2
Kazakhstan
2
Guinea
1
Liberia
1
Ethiopia
1
Turkey
1
Tanzania
1
Rwanda
1
Indonesia
1
South Africa
1
Bangladesh
1
Namibia
1
Middle East and North Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Other region
1
Asia
1
Timor Leste/ East Timor
1
Iran
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
70
Public Health
28
Clinical Guidelines
13
Key Resources
11
Women & Child Health
10
Capacity Building
3
Toolboxes
Planetary Health
23
NCDs
21
Mental Health
12
Global Health Education
10
COVID-19
10
HIV
5
AMR
5
Refugee
3
Rapid Response
2
TB
2
Ebola & Marburg
1
Zika
1
Social Ethics
1
Caregiver
1
NTDs
1
Health Financing Toolbox
1
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
Health is routinely considered in strategic environmental assessment (SEA) and environmental impact assessment (EIA), following requirements of European Union directives and the Protocol on Strategic Environmental Assessment to the Convention on Environmental Impact Assessment in a Trans
...
To enhance health co-benefits across urban policies which tackle air pollution and climate change, WHO, in cooperation with various international, national, and local partners, implemented the Urban Health Initiative (UHI) pilot project in Accra, Ghana. The Initiative prompted the health sector to u
...
Mapping Report - Ireland.
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over
...
10–11 May 2016, Catania, Italy
Prescriptions and Actionables for a Healthy and Green Recovery.
The practical steps outlined in this report aim at creating a healthier, fairer and greener world while investing to maintain and resuscitate the economy hit by the effects of COVID-19.
Policy makers, national and local decision-make
...
The Ministry of Health conducted STEPS surveys on adult risk factors surveillance in Myanmar in 2003, 2009 and 2014. Amongst these three surveys, the 2014 one is the most comprehensive, providing an analysis of all States and Regions within Myanmar through not only questionnaires and physical measur
...
Each unit builds on the one prior, and they all combine to provide key information for developing an SBCC strategy. It is not essential, however, to work through the I-Kit from start to finish. Users can choose to focus on specific aspects for which they need support in their emergency communication
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial
...
In response to the COVID-19 outbreak, this guidance provides information on infection and prevention control (IPC) for older people, their friends and families, carers, and healthcare providers. Anyone who manages, works, volunteers or provides care at any type of facilities where older people recei
...
